Table 2 Enrichment and pathway analysis.
From: Analysis of Serum Metabolites to Diagnose Bicuspid Aortic Valve
Category | Total | Hits | P -value | |
---|---|---|---|---|
Disease-associated | ||||
critical illness (cardiogenic shock) | 6 | 3 | 0.0016 | |
Lesch-Nyhan syndrome | 5 | 2 | 0.0189 | |
metabolites affected by exercise | 5 | 2 | 0.0189 | |
early markers of myocardial injury | 14 | 3 | 0.0227 | |
Crigler-Najjar syndrome | glucose-6-phosphate dehydrogenase deficiency | intoxication acetaminophen [dd] | pyruvate kinase deficiency | 1 | 1 | 0.0464 | |
Enzyme-associated | ||||
GMP reductase | 6 | 3 | 0.0101 | |
guanine phosphoribosyltransferase | 6 | 3 | 0.0101 | |
carnitine O-palmitoyltransferase | 3 | 2 | 0.0212 | |
Beta oxidation of fatty acid | 3 | 2 | 0.0212 | |
transport into the mitochondria (carnitine) | 4 | 2 | 0.0400 | |
methenyltetrahydrofolate cyclohydrolase | 4 | 2 | 0.0400 | |
carnitine transferase | 4 | 2 | 0.0400 | |
SNP-associated | ||||
rs10827283 | rs9663087 | 5 | 2 | 0.0385 | |
rs1562861 | 5 | 2 | 0.0385 | |
rs2039334 | 5 | 2 | 0.0385 | |
Location-associated | ||||
skeletal muscle | 45 | 4 | 0.0433 | |
Pathway | ||||
Fatty acid biosynthesis | 49 | 3 | 0.0052 | |
Purine metabolism | 92 | 3 | 0.0290 |